XML 32 R22.htm IDEA: XBRL DOCUMENT v3.22.2.2
OTHER
 9 Months Ended
Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
OTHER OTHER
Cash dividends
Dividends declared in the nine months ended September 30, 2022 were as follows:
Dividend per shareDate declaredDate of recordPayment date
$0.04253/8/20225/2/20225/16/2022
$0.04256/23/20228/1/20228/15/2022
$0.04258/2/202211/1/202211/15/2022
During the nine months ended September 30, 2022, the Company paid dividends of $2.9 million. This included payments made on February 14, 2022, May 16, 2022 and August 15, 2022 of $0.9 million, $0.9 million and $0.9 million to stockholders of record on January 31, 2022, May 2, 2022 and August 1, 2022, respectively, and payments of $0.1 million for dividends payable upon the vesting of restricted shares and performance shares.
In the three months ended September 30, 2022, the Company reduced retained earnings for the accrual of $1.0 million relating to the dividend payable on November 15, 2022. For the nine months ended September 30, 2022, the Company reduced retained earnings for the accrual of $2.9 million relating to the dividend payable on May 16, 2022, August 15, 2022 and November 15, 2022.
On November 1, 2022, the Board of Directors declared a quarterly dividend of 0.0425 per share of common stock payable on February 15, 2023 to stockholders of record on February 1, 2023.
Stock repurchase program
On March 14, 2022, the Company announced that its Board of Directors of the Company authorized the repurchase of up to $20.0 million of the Company’s common stock, replacing the Company’s previously-authorized $10 million share repurchase program. The repurchase authorization permits the Company to effect the repurchases from time to time through open market purchases and privately negotiated transactions. During the nine months ended September 30, 2022, the Company repurchased 389,743 shares for a total cost of $4.7 million and thereafter retired the shares. Please see Part II, Item 2—Unregistered Sales of Equity Securities and Use of Proceeds included in this Quarterly Report on Form 10-Q.
Supplemental cash flow information
Nine Months Ended
September 30,
20222021
(in thousands)
Supplemental disclosure of cash flow information:
Cash paid for interest$10,804 $10,279 
Cash paid for taxes, net of refunds6,527 12,616 
Non-cash investing activities:
Net (loss) on dilution and partial sale of Vasconia ownership$— $(1,673)
Components of accumulated other comprehensive loss, net
Three Months Ended
September 30,		Nine Months Ended
September 30,
2022202120222021
(in thousands)
Accumulated translation adjustment:
Balance at beginning of period$(36,175)$(31,623)$(31,752)$(35,846)
Translation adjustment during period(2,686)(1,122)(7,109)1,059 
Amounts reclassified from accumulated other comprehensive loss (1)
— 1,362 — 3,404 
Translation Adjustment (2,686)240 (7,109)4,463 
Balance at end of period$(38,861)$(31,383)$(38,861)$(31,383)
Accumulated deferred gains (losses) on cash flow hedges:
Balance at beginning of period$1,636 $(1,062)$78 $(1,125)
Change in unrealized gains (losses)
624 528 2,201 (255)
Amounts reclassified from accumulated other comprehensive loss:
Settlement of cash flow hedge (2)
(270)464 (289)1,310 
Net change in cash flow hedges, net of taxes of $92, $(247), $505, $(301)
354 992 1,912 1,055 
Balance at end of period$1,990 $(70)$1,990 $(70)
Accumulated effect of retirement benefit obligations:
Balance at beginning of period$(1,817)$(2,133)$(1,875)$(2,201)
Amounts reclassified from accumulated other comprehensive loss: (3)
Amortization of actuarial loss, net of taxes29 33 87 101 
Balance at end of period$(1,788)$(2,100)$(1,788)$(2,100)
Total accumulated other comprehensive loss at end of period
$(38,659)$(33,553)$(38,659)$(33,553)
(1)Amounts are recorded in equity in (losses) earnings on the unaudited condensed statements of operations.
(2)Amounts reclassified are recorded in interest expense and cost of sales on the unaudited condensed consolidated statement of operations.
(3)Amounts are recorded in selling, general and administrative expense on the unaudited condensed consolidated statements of operations.